登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C94H147NO42
化学文摘社编号:
分子量:
1963.15
UNSPSC Code:
12352211
MDL number:
NACRES:
NA.28
assay
≥99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (890813P-1MG), pkg of 1 × 5 mg (890813P-5MG)
manufacturer/tradename
Avanti Research™ - A Croda Brand
solubility
DMSO: soluble (1mg in 50uL of DMSO turns clear.)
application(s)
vaccine development
shipped in
dry ice
storage temp.
−20°C
General description
VSA-2 is a semisynthetic saponin adjuvant derived from the naturally available Momordica saponin, designed to stimulate antigen-specific humoral and cellular immune responses. It is created by adding a terminal-functionalized side chain to the branched trisaccharide domain at the C3 position of Momordica saponin II (MS II), which is extracted from the seeds of Momordica cochinchinensis Spreng. When compared directly to the clinically validated saponin adjuvant QS-21, VSA-2 demonstrates comparable effectiveness in enhancing both humoral and cellular immune responses.
Application
Vaccine development
Packaging
5 mL Amber Glass Screw Cap Vial (890813P-1MG); 5 mL Amber Glass Screw Cap Vial (890813P-5MG)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持